Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ian Schofield

Executive Editor

Edinburgh, UK
Ian specialises in pharmaceutical regulatory affairs, mainly in the EU and the UK but also in Australia, New Zealand, Canada and certain African markets. His key areas of focus are clinical trials, market access, intellectual property issues, global regulatory alignment and pandemic preparedness. A modern languages graduate, he worked in the European travel industry before joining Scrip in 1985 as a reporter covering the French and Italian markets. He subsequently held posts including Deputy Editor of Scrip and Principal Analyst at Informa, before taking up his current position at the Pink Sheet. As well as writing news, features and analysis, Ian is part of the Ask the Analyst team that produces on-demand tailored reports for subscribers. His non-work interests include cycling, travel, paddleboarding and playing traditional Scottish music.

Latest From Ian Schofield

Australia Proposes Clearer Labeling For Injectables To Ensure Safety & Efficacy

A targeted review of the rules on labeling for injectable medicines is being carried out in advance of a wider updating of labeling requirements that took effect in 2020.

Asia Pacific Australia

Nordic HTA Collaboration Expands To Boost Joint Assessments

The five-country JNHB says that joint assessments mean HTA applications will be handled “efficiently and simultaneously” across the Nordic region, with one point of contact instead of multiple parallel processes.

Europe Health Technology Assessment

New Brazilian Law Shakes Up Clinical Trial Regulation

A new federal law aims to promote the conduct of trials and speed up access to innovative drugs in Brazil.

Brazil Clinical Trials

EMA Advises On Shift From Quadrivalent To Trivalent Flu Vaccines

Marketing authorization holders should file applications to change the composition of centrally authorized flu vaccines by 17 June, says Europe’s drugs regulator.

Europe Vaccines

Swiss Pilot Allows Applicants To Discuss Preliminary Drug Approval Decisions

A new kind of meeting will allow companies to discuss any questions and obtain advice on how to respond to a preliminary approval decision by Swissmedic.

Europe Switzerland

Amended International Health Regulations Give Fresh Momentum To Pandemic Treaty Talks

The amendments agreed by the World Health Assembly include a definition of a pandemic emergency as well as ways to help improve access to health products.

International Coronavirus COVID-19
See All